Clinical trial
Treatment of Hypochondriasis With CBT and/or SSRI
NCT00339079 · Brigham and Women's Hospital, Other · Completed
Key facts
| NCT number | NCT00339079 |
|---|---|
| Title | Treatment of Hypochondriasis With CBT and/or SSRI |
| Official title | Treatment of Hypochondriasis With CBT and/or SSRI |
| Lead sponsor | Brigham and Women's Hospital, Other |
| Collaborators | National Institute of Mental Health (NIMH) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hypochondriasis |
| Intervention type | Behavioral, Drug, Other |
| Interventions | Fluoxetine, Cognitive Behavioral Therapy (CBT), Supportive Therapy, Placebo |
| Enrollment | 195 |
| Start date | Jun 1, 2006 |
| Primary completion | May 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Jun 20, 2006 |
| Last update posted | Apr 25, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: